Search results
Beam Therapeutics (BEAM) Begins Dosing in Phase I/II AATD Study
Zacks via Yahoo Singapore Finance· 6 days agoBeam Therapeutics (BEAM) doses the first patient in a phase I/II study, evaluating in vivo base...
Beam Therapeutics (BEAM) doses the first patient in a phase I/II study, evaluating in vivo base...